Coronavirus channel feed – Endpoints News

Coronavirus channel feed

Moderna says it's reached the required number of Covid-19 cases for its first interim analysis. When is the readout coming?

5 years ago

Government gears for unprecedented challenge of Eli Lilly antibody rollout as efficacy questions linger

5 years ago

As Pfizer's stock surged Monday, Albert Bourla netted $5.6M in stock sales

5 years ago

Covid-19 roundup: Sinopharm touts 'better than expected' PhIII vaccine data; After Pfizer/BioNTech, Russia claims vaccine is 92% effective on slimmer evidence

5 years ago

GV steps up to back Tillman Gerngross’ new antibody play against Covid-19 — and he’s already thinking about the IPO

5 years ago

Covid-19 roundup: With efficacy data in hand, BioNTech talks pricing; Brazil halts Sinovac trial following patient death

5 years ago

Sweeping doubts aside, Eli Lilly beats Regeneron to emergency OK — clearing low dose antibody for quick rollout

5 years ago

Pfizer-BioNTech data lift global faith in Covid-19 vaccines, but set 'extremely high bar' for competitors

5 years ago

Covid-19 roundup: Biden outlines virus plan, names Rick Bright to task force; Arcturus reads out positive Phase I/II vaccine data

5 years ago

Pfizer, BioNTech say Covid-19 vaccine is more than 90% effective, exceeding expert expectations and setting up an EUA submission late this month

5 years ago

Covid-19 roundup: Novartis treatment comes up short in PhIII; Humanigen expands trial, but draws criticism

5 years ago

Covid-19 roundup: Soriot — vaccine could be ready by year's end; WHO omits remdesivir from developing countries plan

5 years ago

Covid-19 roundup: Oxford investigator sees 'small chance' for vaccine rollout by year end; Fosun follows Pfizer with final choice of BioNTech candidate

5 years ago

Covid-19 roundup: CEPI pours $328M into Clover's vaccine; Former Shkreli company licenses potential treatment for $20M

5 years ago

Can a darkhorse synthetic biology Covid-19 vaccine one-up the frontunners? The Gates Foundation, Amgen bet 'yes'

5 years ago

Covid-19 roundup: Russian biotech seeks permission to produce remdesivir generic; Why did BARDA fund plasma company part-owned by Rick Santorum?

5 years ago

CureVac posts an upbeat take on interim PhI Covid-19 vaccine results, with a pivotal study looming. But you'll have to wait on data

5 years ago

In a second big setback for Covid-19 antibody treatment hopes, Regeneron halts enrollment for more severe patients

5 years ago

Covid-19 roundup: Flush with $486M contract, AstraZeneca signs Lonza up to manufacture antibodies; BioNTech's Ugur Sahin expects vaccine data 'in a fortnight'

5 years ago

A p-value of 0.38? NEJM results raise new questions for Eli Lilly's vaunted Covid antibody

5 years ago

Covid-19 roundup: Moderna posts $1.1B in Covid-19 vaccine deposits; Gilead CEO sees potential need for Veklury on a 'seasonal basis'

5 years ago

Regeneron posts second look on Covid-19 antibody cocktail, boosting its case for EUA — but what about symptom alleviation?

5 years ago

Scientists warn Americans are expecting too much from a coronavirus vaccine

5 years ago

Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday

5 years ago

First page Previous page 39 40 414243 44 45 Next page Last page